Clinical Trials
234
Active:15
Completed:82
Trial Phases
5 Phases
Phase 1:7
Phase 2:3
Phase 3:7
+2 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (218 trials with phase data)• Click on a phase to view related trials
Not Applicable
172 (78.9%)Phase 4
29 (13.3%)Phase 1
7 (3.2%)Phase 3
7 (3.2%)Phase 2
3 (1.4%)The Efficacy of Aldehyde Dehydrogenase Enzyme in Essential Tremor Patients: A Single-Center Study
Not Applicable
- Conditions
- Essential Tremor
- First Posted Date
- 2025-08-15
- Last Posted Date
- 2025-08-15
- Lead Sponsor
- Korea University Anam Hospital
- Target Recruit Count
- 40
- Registration Number
- NCT07124507
- Locations
- 🇰🇷
Korea University Anam Hospital, Seoul, Korea, Republic of
The Effect of Repetitive Transcranial Magnetic Stimulation on Cognitive Improvement in Dementia With Lewy Bodies
Not Applicable
Recruiting
- Conditions
- Dementia With Lewy Bodies
- First Posted Date
- 2025-08-14
- Last Posted Date
- 2025-08-14
- Lead Sponsor
- Korea University Anam Hospital
- Target Recruit Count
- 10
- Registration Number
- NCT07122908
- Locations
- 🇰🇷
Korea University Anam Hospital, Seoul, Korea, Republic of
Effects of Enavogliflozin on Coronary Microvascular and Cardiac Function in Obesity
Phase 4
Recruiting
- Conditions
- Obesity and Type 2 Diabetes
- Interventions
- Drug: Placebo
- First Posted Date
- 2025-03-25
- Last Posted Date
- 2025-03-26
- Lead Sponsor
- Korea University Anam Hospital
- Target Recruit Count
- 30
- Registration Number
- NCT06782139
- Locations
- 🇰🇷
Korea University Anam Hospital, Seoul, Korea, Republic of
Once-daily Fluorometholone Vs Twice-daily Cyclosporine in Dry Eye Disease
Phase 4
Completed
- Conditions
- Dry Eye Disease (DED)
- Interventions
- First Posted Date
- 2025-03-14
- Last Posted Date
- 2025-03-14
- Lead Sponsor
- Korea University Anam Hospital
- Target Recruit Count
- 32
- Registration Number
- NCT06876116
- Locations
- 🇰🇷
Korea University Anam Hospital, Seoul, Korea, Republic of
Development of Machine Learning Models to Predict Postoperative GERD Symptom Resolution After Laparoscopic Nissen Fundoplication
Active, not recruiting
- Conditions
- Gastroesophageal Reflux Disease (GERD)Gastroesophageal Reflux (GER)
- First Posted Date
- 2025-03-06
- Last Posted Date
- 2025-06-26
- Lead Sponsor
- Korea University Anam Hospital
- Target Recruit Count
- 112
- Registration Number
- NCT06862037
- Locations
- 🇰🇷
Korea University Anam Hospital, Seoul, Korea, Republic of
- Prev
- 1
- 2
- 3
- 4
- 5
- 20
- Next
News
Truqap Offers New Hope for HR+/HER2- Breast Cancer Treatment in Korea
Truqap (capivasertib), the first AKT inhibitor, is now available in Korea for HR+/HER2- locally advanced or metastatic breast cancer patients with PIK3CA, AKT1, and PTEN mutations.